Michael Scolaro

Michael Scolaro

Oct 28, 2017

Group 6 Copy 166
-2
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Impact of Soylent Consumption on Human Microbiome Composition

    As students carry out their busy lifestyles, many are turning to inexpensive and convenient drink based...

    Ebola video voice-over recording in 10 African local languages

    Ebola virus is spreading rapidly in West Africa. We are sharing a 3D animation explaining the symptoms of...

    A Leap Forward to Cure a Neglected Disease

    The World Health Organization estimates that as many as 11 million people worldwide are infected with the...

    Backer Badge Funded